Press releases
- Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
- Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
- Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Key statistics
On Friday, Gossamer Bio Inc (4GB:FRA) closed at 0.708, 64.00% above the 52 week low of 0.4317 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.709 |
---|---|
High | 0.7095 |
Low | 0.708 |
Bid | 0.6725 |
Offer | 0.699 |
Previous close | 0.65 |
Average volume | 0.00 |
---|---|
Shares outstanding | 226.22m |
Free float | 221.16m |
P/E (TTM) | -- |
Market cap | 167.40m USD |
EPS (TTM) | -1.38 USD |
Data delayed at least 15 minutes, as of May 03 2024 14:29 BST.
More ▼